Metraipolis › archive › dc_90dee2352913
From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions — Europe PMC PMID:41751233
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41751233
- DOI
- 10.3390/biomedicines14020334
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T09:28:55.002Z
- SHA-256 of the archived text
bf758d5b644446f3cc25c67a8a49727ebd159b69af15ad4aaf390e906f040775- Stable URL of this page
https://metraipolis.com/documento/dc_90dee2352913
How to cite
From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions — Europe PMC PMID:41751233 — Europe PMC (en), https://europepmc.org/article/MED/41751233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_90dee2352913 (Metraipolis archive dc_90dee2352913, sha256 bf758d5b644446f3cc25c67a8a49727ebd159b69af15ad4aaf390e906f040775)
BibTeX
@misc{dc90dee2352913,
title = {From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions — Europe PMC PMID:41751233},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41751233},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_90dee2352913; sha256 bf758d5b644446f3cc25c67a8a49727ebd159b69af15ad4aaf390e906f040775},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751233. Agents can read the archived copy with the MCP tool read_document.